Home
About
Overview
Sharing Data
ORCID
Help
History (23)
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation.
The RISE FOR HEALTH study: Methods for in-person musculoskeletal assessment.
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity.
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer.
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer. J Appl Lab Med. 2024 Jan 03; 9(1):76-91.
View in:
PubMed
subject areas
Biomarkers, Tumor
Genomics
Humans
Mutation
Neoplasms
Prognosis
authors with profiles
Melissa Tjota